Search results
AstraZeneca's breast cancer drug combination fails in late-stage trial
Reuters via Yahoo News· 14 hours agoTriple-negative breast cancer remains one of the most challenging forms of disease to treat due to...
US FDA puts partial clinical hold on Zentalis’ cancer drug studies; shares drop
WSAU Wausau· 8 hours ago(Reuters) - Zentalis Pharmaceuticals said on Tuesday the U.S. Food and Drug Administration has...
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
Nano-immunotherapy developed to improve lung cancer treatment
Science Daily· 5 days ago"Nanoparticles have been used for years to deliver targeted medication to tumor cells, while immunotherapy has also had a paradigm-shifting impact on how we treat cancer, ...
Anti-inflammatory drug celecoxib could reduce risk | Newswise
Newswise· 16 hours agoBoston – An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory ...
Their cancers can't be cured. But new treatments are increasing the length, and quality, of their...
Milwaukee Journal Sentinel via Yahoo News· 5 days ago"We want to take away the guesswork to the extent possible that technology allows us, and them give...
Baysient® Launches Therapeutic Drug Monitoring Software for Oncology Biologics
Benzinga· 12 hours agoBaysient®, a leading provider of therapeutic drug monitoring (TDM) software, today announced the launch of TuMinimize™, a web-based nomogram/algorithm designed to optimize ...
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 10 hours agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
Study reveals unexpected mechanism of drug resistance in kidney cancer
Medical Xpress· 6 days agoRapalogs (or rapamycin analogs) are used to treat renal cell carcinoma (RCC) and other tumor types, but their utility is hindered because tumors become resistant over time ...
Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic...
Nature· 2 days agoDelivering bacteria-based drug for cancer therapy is limited by their penetration into extracellular matrix (ECM). Here the authors report effective depletion of ECM with ...